 SUNNYVALE, Calif., March 24, 2022 GLOBE NEWSWIRE -- BioCardia, Inc. NASDAQ:BCDA, a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will report its financial results for the year ended December 31, 2021 and provide a corporate update conference call on Tuesday, March 29, 2022 at 4:30 PM ET. Following managements formal remarks, there will be a question and answer session. 